TNGX Trading Analysis - 11/19/2026 04:55 PM — TRU-SENTIMENT

TNGX (Tango Therapeutics Inc.) at $22.75. True Sentiment Bearish, delta 40-60 call 34% / put 66%, call $241,950 vs put $480,060. RSI 51.1.

TRU-SENTIMENT · DeltaNeutral

TNGX Trading Analysis - 11/19/2026 04:55 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

TNGX (Tango Therapeutics Inc.) at $22.75. True Sentiment Bearish, delta 40-60 call 34% / put 66%, call $241,950 vs put $480,060. RSI 51.1.

Symbol
TNGX
Price
$22.75
Article bias (separate from True Sentiment)
bearish
Conviction
medium
Published
2026-11-19 16:55:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Overall sentiment: Bearish

Call Volume: $241,950 (33.5%) Put Volume: $480,060 (66.5%) Total: $722,010

Only 8 of 468 options analyzed met delta 40-60 filter (1.7%). Put dollar volume double calls; 1,073 put contracts vs 657 call. Pure directional conviction leans bearish near-term. Divergence: price rose 3.5% on 2026-11-19 (22.02→22.79) while options flow skewed puts — sentiment lags or fades rally.

Note: Options flow shows heavy put buying at Delta 40-60 range, bearish directional read.

Key Statistics: TNGX

$22.71 +3.16%
52-Week Range
$7.83 - $34.39
Market Cap
$3.85B
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
0.99
Next Earnings
N/A
Avg Volume
$2.48M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-1.37
Market cap$3.85B
Shares outstanding169.5M

Dividend

Dividend yield0.00%

Risk & range

Beta0.99
52-week low$7.83
52-week high$34.39
Historical volatility95.8%

Ownership & trading

Institutional ownership47.2%
Average daily volume4.0M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge for context only and are separated from the data-driven analysis below:

  • TNGX (Tempus AI–related genomics/AI biotech name) reported Q3 pipeline progress with updated trial readouts in October 2026, sparking a volume spike to 14.1M shares on 2026-10-23 per historical context.
  • Mid-November sector rotation out of small-cap biotech pressured TNGX after a 30-day high of $27.65 set on 2026-10-22.
  • No confirmed near-term earnings date in provided data; fiscal year end listed as 2025-12-01 with next major options expiration 2026-12-18.
  • Headlines of broader AI-healthcare funding cuts may align with the bearish options flow seen in embedded sentiment data (66.5% put dollar volume).
  • Context: News-driven volatility likely contributed to the 95.81% historical volatility and elevated ATR of $1.96 in fundamentals/indicators.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing EPS is -$1.37; company is unprofitable with no positive earnings trend available.
  • Trailing PE, forward PE, PEG ratio, price-to-book, profit margins, ROE, and revenue growth are all null — no profitability or valuation multiples disclosed.
  • Market cap is $3.85B with 169.46M shares outstanding; beta 0.99 (market-neutral correlation).
  • Institutional ownership 47.21%; dividend yield 0.0% (no income).
  • 52-week range $7.83–$34.39; current price $22.79 sits in lower-middle of annual range.
  • Average volume 4.01M vs 20-day avg 2.83M — recent volume below annual mean.
  • Historical volatility 95.81% signals extreme movement risk.
  • Analyst consensus, target mean price, and recommendation key are null — no street view provided.
  • Fundamentals (no earnings, high volatility) diverge from mildly corrective technical picture (RSI 51.06, price below SMAs).

Current Market Position

Current price from indicators: $22.79 (2026-11-19 close). Daily history shows close $22.79 on 2026-11-19 after intraday high $23.66 and low $22.09. Prior day closed $22.02 (2026-11-18).

Minute bars (2026-11-18 to 2026-11-19) show open $22.03, early dip to $21.27 low, recovery to $22.94 by 15:50 then $22.76 at 15:55. Final session volume 105,146 shares in last bar indicates late-day selling pressure.

Support
$21.27
Resistance
$23.66
20-day SMA
$23.11
50-day SMA
$23.51
Bollinger Lower
$20.63

Technical Analysis

Technical Indicators

RSI (14)
51.06
MACD
-0.05
Signal
-0.04
Hist
-0.01
SMA 5
23.34
SMA 20
23.11
SMA 50
23.51
ATR 14
1.96

SMA alignment: SMA 50 ($23.51) > SMA 5 ($23.34) > SMA 20 ($23.11); price $22.79 below all three — bearish stack. No golden/death cross on provided lags. RSI 51.06 = neutral momentum. MACD -0.05 below signal -0.04, histogram -0.01 = mild bearish. Bollinger mid $23.11, upper $25.60, lower $20.63 — price near lower third (squeeze absent). 30-day range $20.74–$27.65; price at 29% of range.

True Sentiment Analysis (Delta 40-60 Options)

Overall sentiment: Bearish

Call Volume: $241,950 (33.5%) Put Volume: $480,060 (66.5%) Total: $722,010

Only 8 of 468 options analyzed met delta 40-60 filter (1.7%). Put dollar volume double calls; 1,073 put contracts vs 657 call. Pure directional conviction leans bearish near-term. Divergence: price rose 3.5% on 2026-11-19 (22.02→22.79) while options flow skewed puts — sentiment lags or fades rally.

Note: Options flow shows heavy put buying at Delta 40-60 range, bearish directional read.

Key Price Levels (Observational Only)

Daily Low 11-19
$22.09
30d Low
$20.74
SMA 20
$23.11
SMA 50
$23.51
Boll Upper
$25.60

Interactive charts load with JavaScript. This text is the crawlable summary.